Loading…

The regulatory mechanism of ion permeation through a channelrhodopsin derived from (MvChR1)

The five glutamate (E) residues of transmembrane (TM)-2 of channelrhodopsin (CrChR)-2 are conserved among several members of the ChR family. A point mutation of one of them, E97, to a nonpolar alanine (E97A) reduced the photocurrent amplitude without influencing other photocurrent properties. The ch...

Full description

Saved in:
Bibliographic Details
Published in:Photochemical & photobiological sciences 2016-03, Vol.15 (3), p.365-374
Main Authors: Watanabe, Shota, Ishizuka, Toru, Hososhima, Shoko, Zamani, Alemeh, Hoque, Mohammad Razuanul, Yawo, Hiromu
Format: Article
Language:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The five glutamate (E) residues of transmembrane (TM)-2 of channelrhodopsin (CrChR)-2 are conserved among several members of the ChR family. A point mutation of one of them, E97, to a nonpolar alanine (E97A) reduced the photocurrent amplitude without influencing other photocurrent properties. The charge at this position is also the determinant of the Gd 3+ -dependent block of the channel. It has thus been suggested that E97 interacts with hydrated cations to facilitate their permeation and that these residues are the primary binding sites of Gd 3+ . However, the counterpart of this position is alanine for MvChR1 from Mesostigma viride . Here we investigated the ion permeation and the Gd 3+ -dependent channel block of MvChR1. We found that the high-affinity binding site of Gd 3+ was absent in MvChR1, but was dependent on the negativity at this position. However, the ion permeation through the channel was markedly interfered with a negative charge at this position. Based on these findings, it is proposed that the ions can pass through the pore with minimal interaction with this position. MvChR2 was rather insensitive to Gd 3+ because of the absence of negativity at the 116th position, which is glutamate in the case of channelrhodopsin-2 (CrChR2) or the C1C2.
ISSN:1474-905X
1474-9092
DOI:10.1039/c5pp00290g